valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$58.00 ComplexityAverage Updated
$44.66 $147.29
bear $44.66 base $100.80 bull $147.29 margin of safety $58.00 market price* $66.03
Cognizant is a large global IT services company. It builds, runs and modernizes technology systems for big enterprises, mainly in financial services, health sciences, products and resources, and communications and media, and bills largely for its people's time and for multi-year managed-services contracts. Most of its roughly 357,000 staff work from India. Revenue was $21.1 billion in 2025 and $10.9 billion in the first half of 2026, up 5.2%. It has been buying specialist firms for cash: Belcan (engineering services for aerospace and defense) in August 2024, 3Cloud (Microsoft Azure and AI services, $733 million) on January 1, 2026, and Astreya (IT infrastructure and managed services, about 2,600 staff, $634 million) on June 22, 2026. How we measure earnings. We start from cash generated by operations, remove swings in receivables and payables, subtract stock-based pay as a real cost, and subtract the capital spending needed to keep the business running (only the small slice tied to revenue growth is excluded). We then add back the cash interest paid ($36 million in 2025) so that we value what the business earns before its lenders, and deduct what it owes at the end. Amortization of purchased customer relationships is added back because it writes off past acquisition spending; we do not let those purchased relationships drive growth, and the bear case lets the business wind down. The roughly $390 million 2025 tax charge from writing off a tax asset after the 2025 U.S. tax law change had no cash cost and does not reduce these figures. Restructuring cash costs are not removed: Cognizant has restructured repeatedly (2019, 2023, 2024 and now 2026), so we treat them as a normal cost of doing business. Starting level. We use 2021 to 2025, the business as it has run since its 2019-2020 reorganization. Before interest it earned between $2.07 billion and $2.81 billion a year; the middle year is about $2.33 billion, or about $5.16 per share on about 452 million diluted shares (share buybacks have cut the count from 528 million in 2021; 450 million were outstanding in July 2026). 2025 was the best year at $2.81 billion, up about 27% on 2024, helped by the end of the 2023-2024 restructuring program. Base case (about $100.80 per share). Year one is $2.50 billion ($5.53 per share). That is about 7% above the starting level but about 11% below what the business actually earned in 2025, far below 2025's 27% growth, for two dated reasons in the 2026 filings: the new Project Leap restructuring, which management expects to cost $230-320 million, substantially all in 2026, and the earnings that 3Cloud and Astreya add after about $1.37 billion of cash was spent on them. After that we credit 3% a year through year six and 2% through year ten, close to what the business has grown on its own; no future acquisitions, no margin expansion and no AI windfall. Earnings then hold flat in dollars for twenty years and shrink 3% a year after that. What keeps them going is a base of long-running contracts with large enterprises that Cognizant has renewed through every technology shift since the 1990s; trailing-twelve-month bookings were $29.1 billion at June 30, 2026, up 5%. The business is worth about $46.6 billion. It owes about $1.56 billion of bank debt (a term loan and a $1.0 billion revolver draw taken to help fund Astreya) plus small finance leases, against about $1.05 billion of cash and short-term investments, of which we treat roughly $0.5 billion as needed to run the business. Net debt is about $1.03 billion, leaving about $45.6 billion, or about $100.80 per share. Bear case (about $44.66 per share). Cognizant's own filings warn that AI-based tools may reduce demand for its services or its ability to obtain favorable pricing. The bear case assumes that happens alongside an ordinary IT spending downturn: year one starts at $2.20 billion and falls 6% a year to about $1.83 billion ($4.04 per share) in year four, about 22% below the starting level. That depth matches the company's own history, when the business's earnings before interest fell about 24% from 2018 to 2019 as growth stalled and it restructured. Earnings stay there through year ten, shrink 5% a year from year eleven and end after year twenty-five. The business is worth about $21.2 billion; after the same $1.03 billion of net debt, shares are worth about $44.66. Even here earnings cover the roughly $80 million annual interest bill more than twenty times. The India tax dispute over a 2016 share repurchase, where the tax department claims an extra $367 million, is already funded by a $384 million deposit held with the authorities; losing it would forfeit that deposit but would not add new debt, so it does not change the figure. Bull case (about $147.29 per share). Year one is $2.90 billion ($6.42 per share), roughly the 2025 level plus 3Cloud and Astreya for a full year. Belcan engineering, the Azure business and Cognizant's AI-enabled services then keep growth at 4% a year through year five and 3% through year ten, followed by 2% for another decade, then flat. The business is worth about $67.6 billion; less the same net debt, about $147.29 per share. Debt. The term loan and the $1.85 billion revolving credit facility both mature in October 2027, so about $1.56 billion must be refinanced or repaid within about a year. With business cash flow of about $2.5 billion a year in the base case and a leverage covenant far from binding, this is easily handled in every case. The debt floats at below 6%, a small benefit we do not count. What changed. Our previous estimates were $47, $108 and $138 per share. Since then Cognizant spent $634 million on Astreya and borrowed $1.0 billion on its revolver while buying back $1.6 billion of shares in the first half of 2026, turning about $0.4 billion of net cash into about $1.0 billion of net debt. It also launched Project Leap, a 2026 restructuring aimed at AI-led efficiencies, which lowers our base year one. Against that, the share count fell from about 477 million to about 452 million, so each share owns more of the business, and second-quarter operating profit rose to $874 million from $817 million, easing the margin worry raised by the first quarter. The bull case is higher because both 2026 acquisitions now count for a full year. What could make this wrong. The central question is whether AI tools shrink the billable work behind most of Cognizant's revenue faster than its new AI services replace it. Second-quarter bookings fell 6% from a year earlier even as trailing-year bookings grew, and Project Leap is itself a bet on doing more with fewer people. If Cognizant's earnings simply hold at about $2.2 billion before interest with no growth at all, the shares would be worth about $73.84. Margin-of-safety price. We are fairly sure of the earnings level: five years of cash earnings in a $2.07-2.81 billion band, almost no debt relative to earnings, and no customer large enough to sink it. The worst plausible outcome is a structural cut in billable hours from AI that no case fully captures, but the business has light assets, little debt and pays a $1.32 annual dividend, so it would shrink rather than break. If we are wrong about growth (flat earnings) the shares are worth about $73.84; if the bear case arrives, about $44.66. The margin-of-safety price is $58. From $58, the base case value three years out of about $102.37 plus about $3.96 of dividends implies roughly a 22% yearly return; the bear case implies a loss of about 23%, a risk accepted in setting the price because the bear path requires a decline as deep as the company's worst recent setback and lasting a decade, and because buybacks at low prices increase each remaining share's claim on earnings.
Fiscal yearOwner's earningsMethodology
2025 $5.68 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$2,883M; WC movement (AR -366, other curr/noncurr assets -118, AP -2, deferred rev +55, other curr/noncurr liab +93) = $(338)M; SBC=$181M; capex=$288M; capex_ratio=1.893%; revenue 2025=$21,108M vs 2024=$19,736M, delta=$1,372M, growth capex=$25.97M, maintenance capex=$262.03M; OE=2883-(-338)-181-262.03=$2,777.97M; diluted shares=489M; OE/sh=$5.68. Source: FY2025 10-K, accession 0001058290-26-000008. Note: FY2025 net income was depressed ~$390M by a one-time non-cash deferred tax charge tied to the OBBBA tax law change (write-off of a deferred tax asset for R&E costs capitalized outside the US); since this is non-cash it does not distort CFO-based owner earnings. FY2025 also includes a $62M non-cash gain on sale of property, backed out of CFO by the filer.
2024 $4.36 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$2,124M; WC movement (AR -49, other curr/noncurr assets -386, AP -23, deferred rev +44, other curr/noncurr liab -96) = $(510)M; SBC=$175M; capex=$297M; capex_ratio=1.893%; revenue 2024=$19,736M vs 2023=$19,353M, delta=$383M, growth capex=$7.25M, maintenance capex=$289.75M; OE=2124-(-510)-175-289.75=$2,169.25M; diluted shares=497M; OE/sh=$4.36. Source: FY2025 10-K, accession 0001058290-26-000008. Includes dilutive impact of Belcan acquisition (closed Aug 2024) and its associated NextGen restructuring.
2023 $4.01 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$2,330M; WC movement (AR -43, other curr/noncurr assets +123, AP -23, deferred rev -4, other curr/noncurr liab -242) = $(189)M; SBC=$176M; capex=$317M; revenue declined 2023 ($19,353M) vs 2022 ($19,428M) so growth capex=$0, maintenance capex=total capex=$317M; OE=2330-(-189)-176-317=$2,026M; diluted shares=505M; OE/sh=$4.01. Source: FY2025 10-K, accession 0001058290-26-000008. Note: FY2023 restructuring charges of $229M under the 'Fit for Growth'/NextGen program are cash items already reflected within CFO.
2022 $4.46 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$2,568M; WC movement (AR -238, other curr/noncurr assets +343, AP -11, deferred rev -26, other curr/noncurr liab -392) = $(324)M; SBC=$261M; capex=$332M; capex_ratio=1.893%; revenue 2022=$19,428M vs 2021=$18,507M, delta=$921M, growth capex=$17.43M, maintenance capex=$314.57M; OE=2568-(-324)-261-314.57=$2,316.43M; diluted shares=519M; OE/sh=$4.46. Source: FY2022 10-K, accession 0001058290-23-000027.
2021 $4.72 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$2,495M; WC movement (AR -407, other curr/noncurr assets +348, AP -35, deferred rev +19, other curr/noncurr liab -413) = $(488)M; SBC=$246M; capex=$279M; capex_ratio=1.893%; revenue 2021=$18,507M vs 2020=$16,652M, delta=$1,855M, growth capex=$35.12M, maintenance capex=$243.88M; OE=2495-(-488)-246-243.88=$2,493.12M; diluted shares=528M; OE/sh=$4.72. Source: FY2022 10-K, accession 0001058290-23-000027.
2020 $3.43 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$3,299M; WC movement (AR +264, other curr/noncurr assets +73, AP +109, deferred rev +65, other curr/noncurr liab +302) = $813M; SBC=$232M; capex=$398M; revenue declined 2020 ($16,652M) vs 2019 ($16,783M) so growth capex=$0, maintenance capex=total capex=$398M; OE=3299-813-232-398=$1,856M; diluted shares=541M; OE/sh=$3.43. Source: FY2022 10-K, accession 0001058290-23-000027.
2019 $3.22 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$2,499M; WC movement (AR +37, other curr/noncurr assets +159, AP +8, deferred rev +56, other curr/noncurr liab -159) = $101M; SBC=$217M; capex=$392M; capex_ratio=1.893%; revenue 2019=$16,783M vs 2018=$16,125M, delta=$658M, growth capex=$12.46M, maintenance capex=$379.54M; OE=2499-101-217-379.54=$1,801.46M; diluted shares=560M; OE/sh=$3.22. Source: FY2019 10-K, accession 0001058290-20-000008. Note: FY2019 restructuring charges of $217M under the company's cost-optimization program are cash items already reflected within CFO.
2018 $4.08 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$2,592M; WC movement (AR -365, other curr/noncurr assets -8, AP -4, deferred rev -86, other curr/noncurr liab +56) = $(407)M; SBC=$267M; capex=$377M; capex_ratio=1.893%; revenue 2018=$16,125M vs 2017=$14,810M, delta=$1,315M, growth capex=$24.89M, maintenance capex=$352.11M; OE=2592-(-407)-267-352.11=$2,379.89M; diluted shares=584M; OE/sh=$4.08. Source: FY2019 10-K, accession 0001058290-20-000008.
2017 $2.93 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$2,407M; WC movement (AR -249, other curr assets -181, other noncurr assets -89, AP +16, deferred rev +18, other curr/noncurr liab +671) = $186M; SBC=$221M; capex=$284M; capex_ratio (2016-2025 mean capex/revenue)=1.893%; revenue 2017=$14,810M vs 2016=$13,487M, delta=$1,323M, growth capex=$25.0M, maintenance capex=$258.96M; OE=2407-186-221-258.96=$1,741.04M; diluted shares=595M; OE/sh=$2.93. Source: FY2017 10-K, accession 0001058290-18-000009.
2016 $2.62 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$1,645M (restated, FY2017 10-K); WC movement (AR -330, other curr assets -104, other noncurr assets -59, AP +6, deferred rev -38, other curr/noncurr liab +54) = $(471)M; SBC=$217M; capex=$300M; no prior-year revenue available to compute growth capex so maintenance capex=total capex=$300M; OE=1645-(-471)-217-300=$1,599M; diluted shares=610M; OE/sh=$2.62. Source: FY2017 10-K, accession 0001058290-18-000009.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
North America (about 75% of revenue, mainly the United States across the Northeast, Midwest, South and West, plus Canada); United Kingdom (about 9%); Continental Europe (about 10%); Rest of World (about 6%), including India, Australia and Japan.
Historical growth strategy
Organic growth from long-running outsourcing and consulting relationships with large enterprises, delivered mostly from offshore centers in India, topped up by a steady stream of cash-funded acquisitions of specialist firms (Belcan in 2024, 3Cloud and Astreya in 2026), while returning most remaining cash through buybacks and a quarterly dividend.
Chart analysis
A chartist would see a stock that spent years in a broad sideways range, roughly $55 to $90, and then broke down in 2026: the shares lost well over a third from their 52-week high near $87 to a low near $45, breaking below the $60-65 shelf that had held as support since 2022 and falling under both long-term moving averages. A partial rebound followed in mid-2026, but a technician would treat the old $60-65 support as overhead resistance now. Until the price reclaims that zone and a rising 200-day average, the trend reads as down, with the 52-week low in the mid-$40s as the level that must hold to argue a base is forming.
Competitors

Companies we consider competitors of CTSH. Tap a ticker to open our analysis of that company in a new tab.

Circle of competence

We don't have circle of competence information for this company yet.